Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Rehabilitation of Memory in Neurological Disabilities - Pilot study
ISRCTN ISRCTN92582254
ClinicalTrials.gov identifier
Public title Rehabilitation of Memory in Neurological Disabilities - Pilot study
Scientific title A comparison of the effectiveness of two types of neuropsychological rehabilitation for memory deficits following brain damage: A single blind randomised controlled trial
Acronym ReMIND - Pilot study
Serial number at source N0192147133
Study hypothesis The aim of this study is to compare the effectiveness of two types of cognitive rehabilitation techniques (ie restitution and compensation) in reducing memory deficits following brain damage.
Lay summary
Ethics approval Ethical approval obtained from Central Office for Research Ethics Committees, Nottingham Research Ethics Committee 1 (12 May 2004)
Study design Single blind randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke, Traumatic Brain Injury (TBI), Multiple Sclerosis (MS) / memory deficits
Participants - inclusion criteria Prior to July 2008:
Participants having sustained a brain damage, verified by hospital or GP records, should have a memory deficit, defined as overall profile score of 1 (poor memory) or 0 (impaired) on the Rivermead Behavioural memory Test (RBMT), over 18 years of age, living in or around Nottingham (within 50 miles radius), having at least one identified individual who will supervise homework assignments, they give informed consent, they are not blind or deaf, should speak English, should have been diagnosed at least one month prior to recruitment to the study, should be more than one month post injury and or diagnosis, no previous diagnosis of brain damage or other severe disability.

Modified July 2008:
Participants with a stroke, TBI, or MS, verified by hospital or GP records, should have a memory deficit, defined as overall profile score of 2 (average memory) to 0 (impaired) on the Rivermead Behavioural memory Test-extended version (RBMTE), over 18 years of age, living in or around Nottingham or Derby (within 50 miles radius), having at least one identified individual who will supervise homework assignments, they give informed consent, should speak English, and should be more than one month post injury and or diagnosis.
Participants - exclusion criteria Added July 2008:
Those who are blind or deaf, have previous diagnosis of brain damage or dementia, have severe activity limitations which would restrict them from taking part in assessments or intervention, current psychiatric/mental health problems, and language problems (defined as a score of less than 15 on the Sheffield Screening Test for Acquired Language Disorders).
Anticipated start date 24/05/2004
Anticipated end date 31/01/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants At least 60 patients in each group (restitution group, compensation group, attention placebo group) = 180.
Interventions 1. Restitution group
2. Compensation group
3. Attention placebo group
Primary outcome measure(s) Prior to July 2008:
To assess memory functions, disability, psychological adjustment.

Modified July 2008:
To assess everyday memory functions, based on the Everyday Memory Questionnaire.
Secondary outcome measure(s) Added July 2008:
Objective measures of memory (RBMTE, Doors & People, Memory Aids Questionnaire), mood (GHQ12, Wimbledon Self Report Scale), psychological adjustment (Mental Adjustment to Brain Damage), and extended activities of daily living (Nottingham EADL).
Sources of funding 1. Queen's Medical Centre University Hospital NHS Trust (UK) NHS R&D Support Funding

Added July 2008:
2. Stroke Association (UK) (AHP Research Bursary)
3. Remedi (UK)
Trial website
Publications
Contact name Prof  N  Lincoln
  Address University of Nottingham
University Hospital
Institute of work, Health and Organisations
8 William Lee buildings, Science and Technology Park
University Boulevard
  City/town Nottingham
  Zip/Postcode NG7 2RQ
  Country United Kingdom
  Tel +44 (0)115 87523846
  Fax +44 (0)115 8466625
  Email nadina.lincoln@nottingham.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 11/07/2008
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central